Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Acquisition

23 Nov 2015 07:00

RNS Number : 5271G
Kuala Innovations Limited
23 November 2015
 

23 November 2015

Kuala Innovations Limited

Acquisition of 8.2% of student EdTech company Vemo Education, Inc.

The Board of Kuala Innovations Limited ("Kuala" or the "Company") is pleased to announce that it has agreed to participate in the early stage funding round of privately owned Vemo Education, Inc. and subscribe for 1,000,000 shares, representing 8.2 per cent of the shares (on a fully diluted basis) for cash consideration of US$1 million (one million US Dollars). This will be funded from existing cash resources.

 

VEMO is an Education Technology company working with U.S.-based colleges and universities to provide a technology platform for income-based student financing programs in the US$1.3 trillion student debt market in the United States. Vemo was founded to address this student debt crisis by developing income share agreement ("ISA") programmes and deferred tuition plans and partnering with higher education institutions to make these funding options available to students.

 

As student debt has reached a crisis point in the U.S., a solution is needed to combat this growing debt and help offer alternative funding options for students entering higher education. Income-based student financing powered by a strong technology platform is a pioneering effort by VEMO and represents a ground floor opportunity for Kuala.

 

The founder of VEMO, Mr. Lorne Abony, is a well-known technology and media entrepreneur whose many successful tech ventures included Fun Technologies, an AIM listed company which he founded and sold for Cdn$484 million to Liberty Media in 2005. In his role as CEO of Mood Media Inc, a public company which was listed on both the Toronto and London Stock Exchanges, Mr. Abony oversaw offices in 48 countries, employing over 2,300 employees. In addition to his board seat at VEMO, he is also an executive director of Glu Mobile and Chairman of its Strategy Committee. As the founder and CEO of a number of successful ventures, Mr. Abony has raised in excess of US$1 billion through public and private debt and equity markets.

 

VEMO's management team has extensive experience in education finance and the financial aid sector. The team's expertise on legal and regulatory compliance, intricate data science capabilities and institutional and constituent understanding enables VEMO efficiently to deliver student-centric, value-oriented alternatives to traditional financing options.

 

· VEMO Chief Executive Tonio DeSorrento is considered one of the foremost experts on income share agreements in the U.S., having contributed to their development since 2007. Prior to VEMO, he was Deputy General Counsel at Social Finance Inc. (SoFi) and currently serves as an adjunct professor of law at Georgetown University.

· VP of Higher Education Bill Brosseau has worked in the industry for over 20 years and is highly respected by and connected to key decision makers at colleges and universities across the country.

· Dr. Jeff Weinstein, VP of Credit and Analytics, has held the role of Chief Data Scientist at student financing companies and has applied that forecasting experience to the proprietary credit model used by VEMO.

VEMO has a robust business model, which the Board believes will provide it with significant revenue streams as the business evolves. As the originator and master servicer of income share agreement programmes and deferred tuition plans, VEMO's revenues will consist of recurring fees paid to the company directly by colleges and universities.

Commenting on the VEMO Investment, Kuala Co-Chairman Mr Stephen Dattels noted:

"Although Kuala is a new company, it is fortunate to benefit from my long association with Lorne Abony, and I really appreciate Lorne inviting Kuala to participate in this early round of funding which was only open to a select group of investors.

VEMO has first mover advantage in the massive student financing opportunity in the United States. With its infrastructure and technology platform in place to fully develop and service income-based repayment options, including income share agreement programmes (ISA's) and deferred tuition plans, as well as advanced partnership negotiations in progress with leading U.S. universities, the Board believes this seed round investment by Kuala helps to further solidify VEMO's position as the leader in the next generation of student financing. The market is huge and VEMO is positioned to grow as ISA funding programmes are utilised to deal with the student funding crisis."

Commenting on the Kuala investment, VEMO Executive Chairman Mr Lorne Abony noted:

"At US$1.3 trillion and growing, the United States has a student debt crisis with few solutions. VEMO's income-based student financing products will allow students to unlock and monetise their greatest asset, which is the present value of their future earning potential. Kuala's investment allows us to expand company operations, including developing a sales and servicing team to secure partnerships with higher education institutions and implement VEMO's technology platform. VEMO is poised to take student financing to a new level and provide students with the opportunity to graduate from college without a huge student debt burden."

ABOUT VEMO

VEMO was founded to address the burgeoning student debt crisis in U.S. by creating programmes to help higher education institutions better align their costs with their value for students. At US$1.3 trillion, student debt stands second only to home mortgages as the largest source of borrowing. Federal student loan programmes are at the core of this debt, at about US$1.1 trillion, with US$200 billion generated through private lenders. Class of 2015 graduates who took out student loans to fund their education are leaving higher education with an average of US$35,000 in student debt to pay back.

 

VEMO's mission is to help address this crisis by partnering directly with higher education institutions to develop customised financing programs for their students. The company provides a full-service approach for income-based student financing programs including income share agreement and deferred tuition plans, offering a range of services such as custom product design, developing the legal, regulatory and compliance framework, and managing origination and servicing. VEMO can customise programmes for each institution's specific student needs rather than taking a one-size-fits-all approach.

 

VEMO has invested in the infrastructure required to design, price, originate, disburse, and service income-based repayment products. At the core of this infrastructure is a robust technology platform built to maximise big data analytics and data science to create better outcomes for students. VEMO's income forecast engine and proprietary pricing and risk model is powered by this platform. VEMO also employs other backend tools to ensure a frictionless experience for the user, including online applications and disbursements and 24-hour customer service support.

 

VEMO is currently in negotiations with a number of higher education institutions across the U.S. to put in place ISA programmes and deferred tuition plans.

 

For the seven months ended 31 October 2015, VEMO had nil revenue and incurred a trading loss of US$988,967 for the period. As at 31 October 2015, VEMO had total net assets of US$1,048,473.

Further details regarding VEMO are available at its website www.vemo.com or contact:

Vemo Education Tel: +1 410 935 7765 Kerry Schneider

 

For further information please visit www.kualainnovations.com or contact:

Kuala Innovations Limited Tel: +44 1481 810 100 Elysium Fund Management Limited

Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396 James Biddle / Michael Cornish

Peterhouse Corporate Finance Limited (Broker) Tel: +44 (0) 20 7469 0930 Guy Miller / Lucy Williams

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of Kuala Innovations Limited and the companies in which it invests. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Kuala Innovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURABRVUAAUAA
Date   Source Headline
17th Nov 202010:30 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.
5th Nov 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
16th Oct 20209:00 amRNSInvestee Company Update: EMMAC Life Sciences
13th Oct 20207:00 amRNSPlacing and Issue of Equity
23rd Sep 20201:30 pmRNSInvestee Company Update: Yooma Corp.
23rd Sep 20207:00 amRNSHolding(s) in Company
22nd Sep 20207:00 amRNSChange of Broker
17th Sep 20203:45 pmRNSResult of AGM
16th Sep 20204:00 pmRNSInvestee Company Update: Juvenescence Limited
8th Sep 20204:00 pmRNSUpdated Key Information Document
27th Aug 20204:30 pmRNSInvestee Company Update: Factom Inc.
26th Aug 20207:30 amRNSNotice of AGM
26th Aug 20207:00 amRNSFinal Results
25th Aug 20202:30 pmRNSInvestee Company Update: Portage Biotech Inc.
24th Aug 20203:15 pmRNSInvestee Company Update: Leap Gaming
18th Aug 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
5th Aug 20207:00 amRNSInvestee Company Update: Leap Gaming
30th Jul 20208:52 amRNSInvestee Company Update: Factom Inc.
30th Jul 20207:45 amRNSInvestee Company Update: Portage Biotech Inc.
28th Jul 202011:55 amRNSInvestee Company Update: EMMAC Life Sciences
22nd Jul 20201:39 pmRNSInvestee Company Update: EMMAC Life Sciences
14th Jul 202010:15 amRNSInvestee Company Update: Yooma Corp.
13th Jul 20205:01 pmRNSResult of Extraordinary General Meeting
9th Jul 20207:00 amRNSInvestee Company Update: Factom Inc.
6th Jul 202010:31 amRNSInvestee Company Update: Leap Gaming
26th Jun 202012:30 pmRNSNotice of EGM & Proposed Updated Investing Policy
22nd Jun 20207:45 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:30 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:00 amRNSInvestee Company Update: Factom Inc.
17th Jun 20201:00 pmRNSInvestee Company Update: Portage Biotech Inc.
2nd Jun 20209:30 amRNSInvestee Company Update: Juvenescence Limited
26th May 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
26th May 20207:00 amRNSInvestee Company Update: Portage Biotech Inc
21st May 20207:00 amRNSInvestee Company Update: Leap Gaming
19th May 20207:30 amRNSInvestee Company Update: EMMAC Life Sciences
18th May 20207:00 amRNSInvestee Company Update re Yooma and Board Changes
12th May 202010:15 amRNSInvestee Company Update: Portage Biotech Inc.
6th May 202012:30 pmRNSInvestee Company Update: Portage Biotech Inc.
23rd Apr 20203:15 pmRNSInvestee Company Update: Entertainment Direct Asia
23rd Apr 20207:00 amRNSHolding(s) in Company
16th Apr 20204:15 pmRNSInvestee Company Update: Portage Biotech Inc.
16th Apr 20202:00 pmRNSInvestee Company Update: Portage Biotech Inc.
14th Apr 20207:00 amRNSCorporate Update
2nd Apr 20207:00 amRNSInvestee Company Update: Factom Inc.
1st Apr 20207:00 amRNSInvestee Company Update: Leap Gaming
31st Mar 20201:15 pmRNSInvestee Company Update: EMMAC Life Sciences
20th Mar 20205:04 pmRNSInvestee Company Update: Entertainment Direct Asia
19th Mar 20202:30 pmRNSInvestee Company Update: Factom Inc.
17th Mar 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.